Steeneck, Christoph

Discovery of Hydroxyamidine Based Inhibitors of IDO1 for Cancer Immunotherapy with Reduced Potential for Glucuronidation. [electronic resource] - ACS medicinal chemistry letters Feb 2020 - 179-187 p. digital

Publication Type: Journal Article

1948-5875

10.1021/acsmedchemlett.9b00572 doi